In stage 3 ( efficacy ) , participants assigned to ceftriaxone in stage 2 received 4 g ceftriaxone , participants assigned to placebo in stage 2 received placebo , and new participants were randomly assigned ( 2:1 ) to 4 g ceftriaxone or placebo .